36C24226Q0844.pdf

Special Notice

*= Required Field Special Notice

SUBJECT* INTENT TO SOLE SOURCE Chemo Compounding NJHCS East Orange, NJ Campus

GENERAL INFORMATION

CONTRACTING OFFICE’S ZIP CODE* 10468-3904

SOLICITATION NUMBER* 36C24226Q0844

RESPONSE DATE/TIME/ZONE 08-31-2026 10 EASTERN TIME, NEW YORK,

USA

ARCHIVE 10 DAYS AFTER THE RESPONSE DATE

RECOVERY ACT FUNDS N

PRODUCT SERVICE CODE* 6505

NAICS CODE* 325412

CONTRACTING OFFICE ADDRESS Department of Veterans Affairs

Network Contracting Office 2

James J. Peters VA Medical Center

130 West Kingsbridge Road

Bronx NY 10468-3904

POINT OF CONTACT*

Morgan Weeks

Morgan.Weeks1@va.gov

Morgan.Weeks1@va.gov

(607) 664-4708

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

AGENCY CONTACT’S EMAIL ADDRESS

EMAIL DESCRIPTION

DESCRIPTION

This is a notice of intent to award a sole source contract and is not a request for quotes.

The Department of Veterans Affairs on behalf of the NJHCS East Orange, NJ Campus intend to award a Firm Fixed Price (FFP), sole source action to a Large Businesses (LB).

Name of Contractor: OPTUM PHARMACY 801, INC.

Street Address: 23620 N 20TH DRIVE

City, State, Zip: PHOENIX, AZ 85085

The prescriptions will be prepared pursuant to a valid order electronically signed by a VA provider credentialled to prescribe HD drugs and verified by a VA pharmacist. The prescription will be faxed to Optum by 11:30 am on the day prior to the intended treatment appointment. The chemotherapy prescription will be compounded according to recognized pharmacy regulatory guidelines.

1. Contractor shall provide shipping in accordance with manufacturers’ requirements for drug stability and refrigeration. The packaging will have all required labeling to identify the contents of the packages as hazardous.

2. Contractor shall deliver the final product to the East Orange facility no later than 8:00am the day of treatment.

3. Contractor shall comply with USP 797 and USP 800 and FDA insanitary guideline regulations and prepare HD drugs using aseptic technique.

4. The final product will be compatible with the Equishield closed system transfer devices and Optum will attach VA East Orange Clinic preferred tubing for administration.

5. Drug Name Unit Estimated Quantity

ADCETRIS INJ SOL 50MG 54 EA:EACH

ONIVYDE INJ 4.3MG/10ML 70 EA:EACH

PACLITAXEL 100MG 314 EA:EACH

CYCLOPHOSPHAMIDE 1GM INJ 10 EA:EACH

MITOMYCIN 20MG INJ 4 EA:EACH

CYCLOPHOSPHAMIDE 500MG INJ 10 EA:EACH

BORTEZOMIB 3.5MG INJ 148 EA:EACH

DOCETAXEL 160MG/8ML 136 EA:EACH

PACLITAXEL 300MG/50ML 56 EA:EACH

FLUOROURACIL 50MG/ML 154 EA:EACH

IRINOTECAN 100MG/5ML INJ 304 EA:EACH

OXALIPLATIN INJ SOL 100MG/20ML 140 EA:EACH

CARBOPLATIN INJ SOL 450MG/45ML 8 EA:EACH

GEMCITABINE HCL INJ SOL 2GM/52.6ML 122 EA:EACH

CISPLATIN INJ SOL 100MG/100ML 16 EA:EACH

HOMEPUMP C 270ML 5ML/HR C270050 16 EA:EACH

DOXORUBICIN HCL INJ SOL 50MG/25ML 12 EA:EACH

DOCETAXEL INJ SOL CONC 20MG/1ML 32 EA:EACH

EASYPUMP II 270ML 5ML/HR 4540018 116 EA:EACH

GEMCITABINE HCL INJ SOL 1GM/26.3ML 58 EA:EACH

BAG GRAVITY 2 LEG EVA 1000ML 64100 4 EA:EACH

CAROPLATIN INJ SOL 150MG/15ML 4 EA:EACH

FLUOROURACIL INJ SOL 50MG/ML 88 EA:EACH

VINCRISTINE SULFATE INJ 2MG/2ML 10 EA:EACH

EASYPUMP II 125ML 5ML/HR 4540006 10 EA:EACH

SET 127" ALARIS LS 20DP 10015861A 660 EA:EACH

HOMEPUMP C 270ML 2ML/HR C270020 6 EA:EACH

ETOPOSIDE INJ SOL 100MG/5ML 118 EA:EACH

EQUASHIELD CATHETER ADAPTOR LL-2C 132 EA:EACH

BAG GRAVITY 2 LEG EVA 2000ML 64105 30 EA:EACH

SET 126" ALARIS LS 20DP 24260007 30 EA:EACH

EQUASHIELD CONNECTOR FC-1 1070 EA:EACH

STERILE WATER FOR INJ 50ML 22 EA:EACH

"EXT SET 19"" 0.2MIC SMTSITE 20350E" 162 EA:EACH

SYRINGE 50ML TEXIUM BONDED 4 EA:EACH

BAG EMPTY EVA 250ML 64045 56 EA:EACH

DEXTROSE 5% INJ 500ML 4 EA:EACH

SODIUM CHLORIDE 0.9% INJ 250ML 236 EA:EACH

EXT SET 10" 0.2MIC MS422 56 EA:EACH

DEXTROSE 5% INJ 250ML 348 EA:EACH

SODIUM CHLORIDE 0.9% INJ 200ML 146 EA:EACH

TEXIUM CLOSED ML W/CAP 100122410500 148 EA:EACH

BAG EMPTY EVA 150ML 64040 68 EA:EACH

SODIUM CHLORIDE 0.9% INJ 1000ML 38 EA:EACH

SODIUM CHLORIDE 0.9% INJ 100ML 134 EA:EACH

SODIUM CHLORIDE 0.9% INJ 50ML 158 EA:EACH

DEXTROSE 5% INJ 50ML MULTI 14 EA:EACH

DEXTROSE 5% INJ 100ML 16 EA:EACH

SODIUM CHLORIDE 0.9% PF INJ 20ML 26 EA:EACH

SODIUM CHLORIDE 0.9% PF INJ 10ML 122 EA:EACH

SYRINGE 50ML LL 309653 162 EA:EACH

SYRINGE 20ML LL 303310 50 EA:EACH

SYRINGE 30ML LL 302832 14 EA:EACH

SYRINGE 10ML LL 302995 6 EA:EACH

SYRINGE 3ML LL 309657 118 EA:EACH

DISPENSING FEE- FACILITY PATIENT 136 EA:EACH

DISPENSING FEE- EXACT VOLUME REQ 156 EA:EACH

This notice is being published in accordance with Federal Acquisition Regulation (FAR) Subpart 5.101 requiring dissemination of information for proposed contract actions. This is a notice of intent to award a sole source contract and is not a request for competitive quotes/proposals. The statutory authority for this sole source procurement is prescribed by FAR 13.105(a).

The Department of Veterans Affairs, New Jersey locations intends to issue a sole source award contract to OPTUM PHARMACY 801, INC., all responsible sources may submit a capability statement demonstrating the ability to provide the requested services, which shall be considered by the agency before the intended award date. Please note, you MUST have a credentialled to prescribe HD drugs and verified by a VA pharmacist and be able to meeting the shipping/delivery requirements above. Interested sources who submit data are responsible for appropriately marking information if it is proprietary in nature.

The Government shall not reimburse interested sources for any information provided. No requests for capability briefings will be honored.

NAICS Code: 325412 – Pharmaceutical Preparation Manufacturing

Veterans Health Administration prohibits the use of gray market items in their Medical Centers. Gray market items are considered to be items outside of the original equipment manufacturer’s intended distribution channels.

This notice is not a request for quotes; however, all responsible sources may submit a capability statement which shall be considered by the Government. All capability statements must be received by no later than 10:00 AM Eastern Standard Time on September 9, 2026. Responses to be submitted to Morgan Weeks, Contracting Officer at Morgan.Weeks1@va.gov. A determination by the Government not to compete this proposed contract based on responses to this notice is solely within the discretion of the Government.